MGLSX | RWIEX | MGLSX / RWIEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 1 year | 22 years | - |
Gain YTD | 12.788 | 13.087 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 437M | 125B | 0% |
Annual Yield % from dividends | N/A | 1.68 | - |
Returns for 1 year | 15.63 | 19.09 | 82% |
Returns for 3 years | N/A | 3.22 | - |
Returns for 5 years | N/A | 38.81 | - |
Returns for 10 years | N/A | 49.45 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GLIFX | 15.97 | 0.09 | +0.57% |
Lazard Global Listed Infrastructure Inst | |||
WFENX | 12.37 | -0.06 | -0.48% |
Allspring International Equity Inst | |||
LOFLX | 13.81 | -0.09 | -0.65% |
Lord Abbett Focused Large Cap Value F3 | |||
PSTAX | 23.07 | -0.54 | -2.29% |
Virtus KAR Capital Growth A | |||
FBTCX | 23.38 | -1.20 | -4.88% |
Fidelity Advisor Biotechnology C |